Tamsyn Harris

Tamsyn Harris

Auto-generated profile, based on publicly available information

Tamsyn Harris

UK Health Security Agency, London, United Kingdom

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2022 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
BLBarbara Livingstone
Barbara Livingstone
TRTamsyn Redpath
Tamsyn Redpath
FNFathimath Naseer
Fathimath Naseer
ABAdele Boyd
Adele Boyd
MMMelanie Martin
Melanie Martin
RPRuth K Price
Ruth K Price
Lack of robust research methodology for assessing ingestive behavior has impeded clarification of the mediators of food intake following gastric bypass (GBP) surgery. To evaluate changes in directly measured 24-h energy intake (EI), energy density (ED) (primary outcomes), eating patterns, and food preferences (secondary outcomes) in patients and time-matched weight-stable comparator participants. Patients [n = 31, 77% female, BMI (in kg/m2) 45.5 ± 1.3] and comparators (n = 32, 47% female, BMI 27.2 ± 0.8) were assessed for 36 h under fully residential conditions at baseline (1 mo presurgery) and at 3 and 12 mo postsurgery. Participants had ad libitum access to a personalized menu (n = 54 foods) based on a 6-macronutrient mix paradigm. Food preferences were assessed by the Leeds Food Preference Questionnaire. Body composition was measured by whole-body DXA. In the comparator group, there was an increase in relative fat intake at 3 mo postsurgery; otherwise, no changes were observed in food intake or body composition. At 12 mo postsurgery, patients lost 27.7 ± 1.6% of initial body weight (P < 0.001). The decline in EI at 3 mo postsurgery (–44% from baseline, P < 0.001) was followed by a partial rebound at 12 mo (–18% from baseline), but at both times, dietary ED and relative macronutrient intake remained constant. The decline in EI was due to eating the same foods as consumed presurgery and by decreasing the size (g, MJ), but not the number, of eating occasions. In patients, reduction in explicit liking at 3 mo (–11.56 ± 4.67, P = 0.007) and implicit wanting at 3 (–15.75 ± 7.76, P = 0.01) and 12 mo (–15.18 ± 6.52, P = 0.022) for sweet foods were not matched by reduced intake of these foods. Patients with the greatest reduction in ED postsurgery reduced both EI and preference for sweet foods. After GBP, patients continue to eat the same foods but in smaller amounts. These findings challenge prevailing views about the dynamics of food intake following GBP surgery. This trial was registered as clinicaltrials.gov as NCT03113305.

1 February 2021 in Obesity Reviews
Verified
Journal Article
Open access
PDF file
TRTamsyn L. Redpath
Tamsyn L. Redpath
BLBarbara Livingstone
Barbara Livingstone
ADAoibheann A. Dunne
Aoibheann A. Dunne
ABAdele Boyd
Adele Boyd
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
RPRuth K. Price
Ruth K. Price
Summary: Gastric bypass surgery is an effective long‐term treatment for individuals with severe obesity. Changes in appetite, dietary intake, and food preferences have all been postulated to contribute to postoperative body weight regulation, however, findings are inconsistent. The aim of this systematic review was to evaluate the current literature on changes in dietary intake and appetite following gastric bypass surgery, in the context of the methodology used and the analysis, interpretation, and presentation of results. Four databases were systematically searched with terms related to “gastric bypass surgery,” “appetite,” and “dietary intake,” and 49 papers (n = 2384 patients after gastric bypass) were eligible for inclusion. The evidence indicated that only a reduction in overall energy intake and an increase in postprandial satiety are maintained beyond 6‐month post‐surgery, whereas relative macronutrient intake and premeal hunger remain unchanged. However, available data were limited by inconsistencies in the methods, analysis, presentation, and interpretation of results. In particular, there was a reliance on data collected by subjective methods with minimal acknowledgment of the limitations, such as misreporting of food intake. There is a need for further work employing objective measurement of appetite and dietary intake following gastric bypass surgery to determine how these mechanisms may contribute to weight regulation in the longer term.

8 September 2021 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
TRTamsyn Redpath
Tamsyn Redpath
FNFathimath Naseer
Fathimath Naseer
RPRuth Karen Price
Ruth Karen Price
ABAdele Boyd
Adele Boyd
MMMelanie Martin
Melanie Martin
BLBarbara Livingstone
Barbara Livingstone
Gastric bypass surgery leads to significant and sustained weight loss and a reduction in associated health risks in individuals with severe obesity. While reduced energy intake (EI) is the primary driver of weight loss following surgery, the underlying mechanisms accounting for this energy deficit are not well understood. The evidence base has been constrained by a lack of fit-for-purpose methodology in assessing food intake coupled with follow-up studies that are relatively short-term. This paper describes the underlying rationale and protocol for an observational, fully residential study using covert, objective methodology to evaluate changes in 24-hr food intake in patients (n = 31) at 1-month pre-surgery and 3-, 12- and 24-months post-surgery, compared to weight-stable controls (n = 32). The main study endpoints included change in EI, macronutrient intake, food preferences, and eating behaviours (speed, frequency, and duration of eating). Other physiological changes that may influence EI and weight regulation including changes in body composition, circulating appetite hormones, resting metabolic rate, total energy expenditure and gastrointestinal symptoms were also evaluated. Understanding which mechanisms contribute to a reduction in EI and weight loss post-surgery could potentially help to identify those individuals who are most likely to benefit from gastric bypass surgery as well as those that may need more targeted intervention to optimise their weight loss post-surgery. Furthermore, clarification of these mechanisms may also inform targeted approaches for non-surgical treatments of obesity.

4 November 2025 in Cochrane Evidence Synthesis and Methods
Verified
Journal Article
Open access
ZSZalaya Simmons
Zalaya Simmons
BEBeti Evans
Beti Evans
THTamsyn Harris
Tamsyn Harris
HWHarry Woolnough
Harry Woolnough
LDLauren Dunn
Lauren Dunn
DDDaphne Duval
Daphne Duval
Introduction: Data extraction is a critical but resource‐intensive step of the evidence review process. Whilst there is evidence that artificial intelligence (AI) and large language models (LLMs) can improve the efficiency of data extraction from randomized controlled trials, their potential for other study designs is unclear. In this context, this study aimed to evaluate the performance of a bespoke LLM model pipeline (Retrieval‐Augmented Generation pipeline utilizing LLaMa 3‐70B) to automate data extraction from a range of study designs by assessing the accuracy and reliability of the extractions measured as error types and acceptability. Methods: Accuracy was assessed by retrospectively comparing the LLM extractions against human extractions from a review previously conducted by the authors. A total of 173 data fields from 24 articles (including experimental, observational, qualitative, and modeling studies) were assessed, of which three were used for prompt engineering. Reliability was assessed by calculating the mean maximum agreement rate (the highest proportion of identical returns from 10 consecutive extractions) for 116 data fields from 16 of the 24 studies. An evaluation framework was developed to assess the accuracy and reliability of LLM outputs measured as error types and acceptability (acceptability was assessed on whether it would be usable in real‐world settings if the model acted as one reviewer and a human as a second reviewer). Results: Of the 173 data fields evaluated for accuracy, 68% were rated by human reviewers as acceptable (consistent with what is deemed to be acceptable data extraction from a human reviewer). However, acceptability ratings varied depending on the data field extracted (33% to 100%), with at least 90% acceptability for “objective,” “setting,” and “study design,” but 54% or less for data fields such as “outcome” and “time period.” For reliability, the mean maximum agreement rate was 0.71 (SD: 0.28), with variation across different data fields. Conclusion: This evaluation demonstrates the potential for LLMs, when paired with human quality assurance, to support data extraction in evidence reviews that include a range of study designs. However, further improvements in performance and validation are required before the model can be introduced into review workflows.

31 March 2026 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
MNMichael Nunns
Michael Nunns
SFSamantha Febrey
Samantha Febrey
KBKieran Becker
Kieran Becker
Morgan WeilandMorgan Weiland
Morgan Weiland
JBJill Buckland
Jill Buckland
GMG J Melendez-Torres
G J Melendez-Torres
Background: Contact tracing (CT), the process of identifying and managing contacts of infected cases, is one public health and social measure that may reduce the spread of infectious diseases. While previous systematic reviews of CT exist, a comprehensive review of both the effectiveness and potential unintended consequences has not been undertaken to our knowledge. Understanding effective CT strategies could help governments and health authorities prepare effectively for emergency epidemic or pandemic situations. Objective: This study aims to systematically review the evidence on the effectiveness of CT across infectious diseases with epidemic or pandemic potential. Effectiveness is measured in terms of impacts on disease transmission, health care use, mortality, or unintended consequences. Methods: We searched 6 bibliographic databases (MEDLINE, Embase, Global Health, CINAHL Ultimate, Cochrane, and Scopus) between November 29 and December 3, 2024, with supplementary citation searching. We sought human studies comparing CT with interventions with no CT or other forms of CT, delivered in the community, in prespecified diseases of epidemic or pandemic potential. We included studies with any measure of disease transmission, related health care use, or unintended consequences of CT and prioritized studies with concurrent comparators. Screening, data extraction, and critical appraisal were performed in duplicate. Due to substantial heterogeneity, a narrative synthesis was performed. This review was informed by meetings with a patient and public involvement and engagement group. Results: After deduplication, a total of 12,816 titles and abstracts were screened, with 198 records assessed for eligibility at full text. Five additional studies were found through supplementary searching. Finally, 88 reports (of 86 studies) were included, of which 57 reports (of 55 studies) were prioritized. Two main routes of transmission were represented: respiratory (tuberculosis [TB], 15 studies; COVID-19, 5 studies) and blood-borne or sexually transmitted infections (STIs; 35 studies, of which 13 were in HIV, and 22 were bacterial or parasitic infections). No evidence was found on vector-borne, direct contact, or food- or water-borne routes of transmission. Evidence was highly heterogeneous, and more than half of the studies had notable methodological limitations. While there was no difference between CT and comparator interventions for most outcomes, there was some evidence of reductions in disease prevalence in TB and for provider-initiated CT to be superior to patient-led approaches in STIs. Only 2 studies reported measures of unintended consequences. Conclusions: We found inconsistent evidence for the effectiveness of CT, focused primarily on TB and on contrasts between provider-initiated CT and patient-led referral in STIs and HIV. High heterogeneity in study design precluded clear assertions regarding optimal strategies for CT, including with respect to relevant subgroups. Future work should consider generalizability of CT mechanisms across contexts, including by route of transmission and from the Global South, and a more thorough account of unintended consequences.

27 December 2025 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
DSDijana Spasenoska
Dijana Spasenoska
NANaemi Araya
Naemi Araya
MSMarieke de Swart
Marieke de Swart
NHNicholas Henschke
Nicholas Henschke
EHEli Harriss
Eli Harriss
LSLouise Sigfrid
Louise Sigfrid
The emergence of a new mpox sub-clade Ib and changes in transmission pattern are of concern. To inform strategies to protect populations and improve outcomes, we implemented a rapid research needs appraisal (RRNA) to identify existing evidence on mpox clade I. We searched Embase, MEDLINE, Scopus, and grey literature to 11 February 2025 for human mpox clade I studies. Of 79 studies identified, 2.5% (2/79) were interventional, 97.4% (77/79) observational, presenting data on 59,183 mpox cases. Most (57/79) focused on clade Ia, 16/79 clade Ib, and 6/79 unspecified sub-clade I. 90.8% were set in Africa. Studies focused on clinical characteristics (n = 55), transmission (n = 23), risk factors for disease/severe disease (n = 13), diagnostics (n = 9), social/behavioural factors (n = 6), immune response/seroprevalence (n = 5), and vaccine/treatments (n = 4). Symptoms and complications were similar for both sub-clades. Three studies reported foetal death in 8/12-8/14 pregnant women infected with clade Ib and in 3/4 of women with clade Ia. The pooled case fatality rate (CFR) was 6% (95% CI 3% to 8%) in clade Ia studies and 1% (95% CI 0% to 1%) in clade Ib studies. There were no studies on effectiveness of prevention, treatment, risk of asymptomatic infection, or immune protection over time. The identified evidence-gaps provide a baseline to inform coordinated research strategies to generate evidence for clinical and public health responses to improve outcomes.